Medicine
Leila Mahboobi; Babak Sandoghchian Shotorbani
Abstract
This case report delves into the intricate management of a 7-year-old girl suffering from Chronic Recurrent Multifocal Osteomyelitis (CRMO), highlighting the pivotal role of Meloxibell, a medication integrating Meloxicam, in her treatment. The patient presented with severe knee pain, progressing to hip ...
Read More
This case report delves into the intricate management of a 7-year-old girl suffering from Chronic Recurrent Multifocal Osteomyelitis (CRMO), highlighting the pivotal role of Meloxibell, a medication integrating Meloxicam, in her treatment. The patient presented with severe knee pain, progressing to hip pain and lameness, prompting referral to the Department of Pediatric Rheumatology. With no underlying diseases in the patient or her parents, diagnostic evaluations revealed elevated CRP and ESR levels. Imaging studies, including ultrasound and MRI, unveiled multifocal bone involvement, and subsequent biopsies confirmed the diagnosis of CRMO. Hospitalization ensued, during which vital signs remained stable, and comprehensive tests yielded normal results. Meloxibell, administered at 7.5mg, demonstrated remarkable efficacy, resulting in the alleviation of symptoms and subsequent discharge. This case underscores the diagnostic challenges inherent in CRMO and sheds light on the potential of Meloxibell as an effective therapeutic agent. The successful outcome observed prompts consideration of Meloxibell as a valuable addition to CRMO management, warranting further research to elucidate its long-term efficacy and safety profile. As CRMO continues to pose diagnostic and therapeutic challenges, this case report contributes valuable insights to the evolving landscape of pediatric rheumatology, emphasizing the need for individualized treatment approaches in this complex disorder.
